Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors.
Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors. J Immunother Cancer. 2022 Oct; 10(10).
View in:
PubMed
subject areas
Acetylglucosamine
Animals
Antigens, Neoplasm
CD8-Positive T-Lymphocytes
Immunotherapy
Melanoma, Experimental
Mice
Mice, Inbred C57BL
authors with profiles
William H Hildebrand
Jason R Krawic